REGULATED INFORMATION
| FY2018 Company report | Upload |
| FY2018 ANNUAL financial report | Upload |
| FY2018 consolidated accounts – 31 december 2018 | Upload |
| auditors report on fy2018 consolidated accounts – 31 december 2018 | Upload |
| FY2018 annual accounts – 31 december 2018 | Upload |
| auditors report on fy2018 annual accounts – 31 december 2018 | Upload |
| HY2018 Financial report – 30 June 2018 | Upload |
| Statutory auditors report on limited review of HY2018 accounts | Upload |
| 2017 "Document de référence" | Upload |
| FY2017 consolidated accounts – 31 december 2017 | Upload |
| auditors report on fy2017 consolidated accounts – 31 december 2017 | Upload |
| FY2017 annual accounts – 31 december 2017 | Upload |
| auditors report on fy2017 annual accounts – 31 december 2017 | Upload |
| HY2017 Financial report – 30 June 2017 | Upload |
| Statutory auditors report on limited review of HY2017 accounts | Upload |
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 may 2024* | 1,705,392 | 1,705,392 |
| 30 april 2024 | 3,455,022,541 | 3,455,022,581 |
| 31 march 2024 | 2,615,022,543 | 2,615,022,583 |
| 29 February 2024 | 1,915,022,543 | 1,915,022,583 |
| 31 January 2024 | 1,094,106,943 | 1,094,106,967 |
*end of the reverse split of Europlasma's shares on 28 May 2024 (see the press release)
Tracking the number of shares outstanding
- This chart (in French) tracks the number of oustanding shares in connection with the set up of bonds financing of up to € 15M over 3 years by OCEANE-BSA's issuance
read the press release
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 december 2023 | 304,637,119 | 304,637,140 |
| 30 november 2023 | 304,608,337 | 304,608,353 |
| 31 october 2023 | 139,078,341 | 139,078,348 |
| 30 September 2023 | 72,706,214 | 72,706,221 |
| 31 august 2023 | 38,476,975 | 38,476,982 |
| 31 july 2023 | 22,526,102 | 22,526,110 |
| 30 june 2023 | 15,385,906 | 15,385,914 |
| 31 may 2023 | 10,250,829 | 10,250,837 |
| 30 april 2023 | 9,175,940 | 9,175,948 |
| 31 march 2023 | 7,803,116 | 7,803,124 |
| 28 february 2023 | 5,587,578 | 5,587,586 |
| 31 JANUARY 2023 | 4,087,578 | 4,087,586 |
- This chart (in French) tracks the number of oustanding shares in connection with the set up of bonds financing of up to € 100M over 7 years by OCABSA's issuance
read the press release - see OCABSA's characteristics
- Europlasma terminates the agreement for the issuance of warrants giving access to notes convertible into shares press release 10/05/2022
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 december 2022 | 4,087,578** | 4,087,582 |
| 30 november 2022 | 40,875,780,635 | 40,875,834,130 |
| 31 october 2022 | 23,542,447,304 | 23,542,499,695 |
| 30 september 2022 | 2,653,558,417 | 2,653,610,307 |
| 31 august 2022 | 1,678,904,285 | 1,679,006,034 |
| 31 july 2022 | 773,002,863 | 773,053,284 |
| 30 June 2022 | 461,397,873 | 461,448,182 |
| 31 may 2022 | 348,947,873* | 348,997,959* |
| 30 april 2022 | 214,533,732 | 214,603,803 |
| 31 march 2022 | 142,140,049 | 142,186,742 |
| 28 february 2022 | 118,932,380 | 118,978,855 |
| 31 JANUARY 2022 | 111,912,937 | 111,959,062 |
* rectified on 2022/07/07 (see press release)
** Following the share consolidation operation ended on 16/12/2022 (see press release)
Tracking the number of shares outstanding
- This chart (in French) tracks the number of oustanding shares in connection with the set up of bonds financing of up to € 100M over 7 years by OCABSA's issuance
read the press release - see OCABSA's characteristics
- Europlasma terminates the agreement for the issuance of warrants giving access to notes convertible into shares press release 10/05/2022
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 december 2021 | 68.522.228 | 68.568.261 |
| 30 november 2021 | 53,337,629 | 53,383,557 |
| 31 october 2021 | 48,031,770 | 48,077,609 |
| 30 september 2021 | 44,466,698 | 44,512,516 |
| 31 August 2021 | 35,522,038 | 35,567,846 |
| 31 july 2021 | 31,665,837 | 31,688,396 |
| 30 june 2021 | 28,204,591 | 28,208,527 |
| 31 may 2021 | 20,134,732 | 20,138,614 |
| 30 april 2021 | 18,413,990 | 18,417,870 |
| 31 march 2021 | 16,600,685 | 16,604,473 |
| 28 February 201 | 14,200,567 | 14,204,324 |
| 31 JANUARY 2021 | 11,626,515 | 11,633,553 |
Tracking the number of shares outstanding
- This chart (in French) tracks the number of oustanding shares in connection with the set up of bonds financing of up to € 100M over 7 years by OCABSA's issuance
read the press release - see OCABSA's characteristics
- This chart (in French) tracks the number of oustanding shares in connection with the issuance of 650 convertible notes into new shares (OCA) in favor of Global Tech Opportunities (read the press release)
See the chart of outstanding shares in connection with OCA in favor of Global Tech Opportunities
- This chart (in French) tracks the number of oustanding shares in connection with the financing through issuance and subscription of convertible notes into new shares (OCA) with attached warrants (BSA) in favor of European High Growth Opportunities Securitization Fund as described in the press release of 06/09/2019.
- This chart (in French) tracks the number of oustanding shares in connection with the financing through issuance and subscription of convertible notes into new shares (OCA) with attached warrants (BSA) in favor of Zigi Capital as described in the press release of 24/06/2019.
See the chart of outstanding shares in connection with OCABSA in favor of Zigi Capital
- This chart (in French) tracks the number of outstanding shares in connection with the financing through issuance and subscritption of warrants giving access to convertible notes into new shares (BEOCA) in favor of European High Growth Opportunities Securitization Fund (EHGOS) as described in the press release of 09/02/2018.
See the chart of oustanding shares in connection with BEOCA in favor of EHGOS
- This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) in favor of Bracknor Fund as described in the press release of 21/07/2016.
See the chart of oustanding shares in connection with OCABSA in favor of Bracknor
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 december 2020 | 10,445,969 | 10,452,493 |
| 30 november 2020 | 9,511,342 | 9,514,697 |
| 31 october 2020 | 8,214,463 | 8,225,009 |
| 30 september 2020 | 8,219,736 | 8,224,997 |
| 31 august 2020 | 8,219,736 | 8,224,993 |
| 31 july 2020 | 7,301,884* | 7,307,115* |
| 30 June 2020 | 9,110,486,000 | 9,121,957,548 |
| 31 may 2020 | 9,110,486,000 | 9,121,891,744 |
| 30 avril 2020 | 6,277,154,950 | 6,288,563,124 |
| 31 mars 2020 | 3,906,694,405 | 3,918,104,730 |
| 29 February 2020 | 2,518,527,739 | 2,529,708,683 |
| 31 JANUARY 2020 | 1,113,676,495 | 1,124,301,607 |
* On 07/06/2020, the Company proceeded with a consolidation of shares at the rate of 1 new share against 2,000 old (see the press release - in French)
Tracking the number of shares outstanding
- This chart (in French) tracks the number of oustanding shares in connection with the issuance of 650 convertible notes into new shares (OCA) in favor of Global Tech Opportunities
See the chart of outstanding shares in connection with OCA in favor of Global Tech Opportunities
- This chart (in French) tracks the number of oustanding shares in connection with the financing through issuance and subscription of convertible notes into new shares (OCA) with attached warrants (BSA) in favor of European High Growth Opportunities Securitization Fund as described in the press release of 06/09/2019.
- This chart (in French) tracks the number of oustanding shares in connection with the financing through issuance and subscription of convertible notes into new shares (OCA) with attached warrants (BSA) in favor of Zigi Capital as described in the press release of 24/06/2019.
See the chart of outstanding shares in connection with OCABSA in favor of Zigi Capital
- This chart (in French) tracks the number of outstanding shares in connection with the financing through issuance and subscritption of warrants giving access to convertible notes into new shares (BEOCA) in favor of European High Growth Opportunities Securitization Fund (EHGOS) as described in the press release of 09/02/2018.
See the chart of oustanding shares in connection with BEOCA in favor of EHGOS
- This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) in favor of Bracknor Fund as described in the press release of 21/07/2016.
See the chart of oustanding shares in connection with OCABSA in favor of Bracknor
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 december 2019 | 855,655,396 | 865,759,033 |
| 30 November 2019 | 662,204,586 | 672,425,334 |
| 31 October 2019 | 541,263,576 | 551,489,608 |
| 30 SEPTEMBER 2019 | 487,122,715 | 497,301,400 |
| 31 august 2019 | 422,997,376 | 431,226,055 |
| 31 july 2019 | 376,518,555 | 384,982,751 |
| 30 June 2019 | 339,335,330 | 347,879,636 |
| 31 maY 2019 | 285,061,,997 | 292,628,687 |
| 30 avril 2019 | 285,061,997 | 292,628,687 |
| 31 March 2019 | 285,062,024 | 292,628,737 |
| 28 february 2019 | 284,480,024 | 292,040,101 |
| 31 JANUARY 2019 | 284,480,024 | 292,135,168 |
Déclaration of transactions on securities
Zigi Capital represented by Jérôme Garnache-Creuillot, Chairman & C.E.O. see the declaration
Zigi Capital represented by Jérôme Garnache-Creuillot, Chairman & C.E.O. see the declaration
Zigi Capital represented by Jérôme Garnache-Creuillot, Chairman & C.E.O. see the declaration
Tracking the number of shares outstanding
- This chart (in French) tracks the number of oustanding shares in connection with the financing through issuance and subscription of convertible notes into new shares (OCA) with attached warrants (BSA) in favor of European High Growth Opportunities Securitization Fund as described in the press release of 06/09/2019.
- This chart (in French) tracks the number of oustanding shares in connection with the financing through issuance and subscription of convertible notes into new shares (OCA) with attached warrants (BSA) in favor of Zigi Capital as described in the press release of 24/06/2019.
See the chart of outstanding shares in connection with OCABSA in favor of Zigi Capital
- This chart (in French) tracks the number of outstanding shares in connection with the financing through issuance and subscritption of warrants giving access to convertible notes into new shares (BEOCA) in favor of European High Growth Opportunities Securitization Fund (EHGOS) as described in the press release of 09/02/2018.
See the chart of oustanding shares in connection with BEOCA in favor of EHGOS
- This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) in favor of Bracknor Fund as described in the press release of 21/07/2016.
See the chart of oustanding shares in connection with OCABSA in favor of Bracknor
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 December 2018 | 284,476,788 | 292,132,697 |
| 30 November 2018 | 265,429,602 | 273,077,215 |
| 31 OCTOBER 2018 | 254,229,532 | 261,889,915 |
| 30 september 2018 | 245,428,844 | 253,068,690 |
| 31 august 2018 | 231,510,121 | 239,112,084 |
| 31 JULY 2018 | 213,009,946 | 220,563,205 |
| 30 June 2018 | 202,411,869 | 209,968,033 |
| 31 May 2018 | 199,810,892 | 207,341,307 |
| 30 April 2018 | 183,908,788 | 192,123,096 |
| 31 MArCH 2018 | 179,255,357 | 187,293,012 |
| 28 FEBRuary 2018 | 166,206,577 | 174,251,173 |
| 31 january 2018 | 152,970,026 | 161,486,914 |
Tracking the number of shares outstanding
This chart (in French) tracks the number of outstanding shares in connection with the financing through issuance and subscritption of warrants giving access to convertible notes into new shares (BEOCA) as described in the press release of 09/02/2018.
See the chart of shares oustanding in connection with BEOCA
Tracking the number of shares outstanding
This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) as described in the press release of 21/07/2016.
See the chart of shares oustanding in connection with OCABSA
| DATE | OUSTANDING SHARES | NUMBER OF THEORICAL VOTING RIGHTS |
|---|---|---|
| 31 DECEMber 2017 | 152,537,636 | 160,451,671 |
| 30 noVEMber 2017 | 152,519,078 | 160,444,792 |
| 31 october 2017 | 152,405,521 | 160,331,705 |
| 30 september 2017 | 152,392,759 | 160,283,325 |
| 31 August 2017 | 146,963,399 | 154,858,986 |
| 31 July 2017 | 143,862,922 | 151,943,073 |
| 30 June 2017 | 139,981,055 | 148,065,084 |
| 31 may 2017 | 131,077,601 | 138,980,348 |
| 30 April 2017 | 127,158,554 | 135,044,557 |
| 31 March 2017 | 127,158,554 | 135,045,233 |
| 28 February 2017 | 116,415,854 | 124,267,670 |
| 31 January 2017 | 116,415,854 | 124,274,214 |
Tracking the number of shares outstanding
This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) as described in the press release of 21/07/2016.
See the chart of shares oustanding in connection with OCABSA
4 February 2019
Begining of the program 05/03/2012
Balance as at 31/01/2019 : 321,000
Number of shares purchased : 0
Number of shares sold : 321,000
6 January 2019
Begining of the program 05/03/2012
Balance as at 31/12/2018 : 324,000
Number of shares purchased : 30,000
Number of shares sold : 33,000
4 December 2018
Begining of the program 05/03/2012
Balance as at 30/11/2018 : 220,000
Number of shares purchased : 150,000
Number of shares sold : 46,000
4 November 2018
Begining of the program 05/03/2012
Balance as at 31/10/2018 : 329,369
Number of shares purchased : 51,001
Number of shares sold : 160,370
6 October 2018
Begining of the program 05/03/2012
Balance as at 30/09/2018 : 255,369
Number of shares purchased : 89,002
Number of shares sold : 15,002
3 September 2018
Begining of the program 05/03/2012
Balance as at 31/08/2018 : 302,819
Number of shares purchased : 58,000
Number of shares sold : 105,450
3 August 2018
Begining of the program 05/03/2012
Balance as at 31/07/2018 : 294,819
Number of shares purchased : 53,005
Number of shares sold : 45,005
2 July 2018
Begining of the program 05/03/2012
Balance as at 30/06/2018 : 249,819
Number of shares purchased : 50,000
Number of shares sold : 5,000
3 June 2018
Begining of the program 05/03/2012
Balance as at 30/05/2018 : 263,819
Number of shares purchased : 66,002
Number of shares sold : 80,002
4 May 2018
Begining of the program 05/03/2012
Balance as at 30/04/2018 : 251,819
Number of shares purchased : 61,001
Number of shares sold : 49,001
2 April 2018
Begining of the program 05/03/2012
Balance as at 31/03/2018 : 156,819
Number of shares purchased : 110,003
Number of shares sold : 15,003
4 March 2018
Begining of the program 05/03/2012
Balance as at 28/02/2018 : 201,819
Number of shares purchased : 70,001
Number of shares sold : 115,001
5 February 2018
Begining of the program 05/03/2012
Balance as at 31/01/2018 : 211,819
Number of shares purchased : 65,000
Number of shares sold : 75,000
6 January 2018
Begining of the program 05/03/2012
Balance as at 31/12/2017 : 200,819
Number of shares purchased : 43,002
Number of shares sold : 32,000
3 December 2017
Begining of the program 05/03/2012
Balance as at 30/11/2017 : 232,819
Number of shares purchased : 18,000
Number of shares sold : 50,000
4 November 2017
Begining of the program 05/03/2012
Balance as at 31/10/2017 : 221,819
Number of shares purchased : 16,000
Number of shares sold : 5,000
7 October 2017
Begining of the program 05/03/2012
Balance as at 30/09/2017 : 235,819
Number of shares purchased : 11,000
Number of shares sold : 25,000
1 September 2017
Begining of the program 05/03/2012
Balance as at 31/08/2017 : 231,219
Number of shares purchased : 19,601
Number of shares sold : 15,001
1 August 2017
Begining of the program 05/03/2012
Balance as at 31/07/2017 : 198,119
Number of shares purchased : 43,100
Number of shares sold : 10,000
1 July 2017
Begining of the program 05/03/2012
Balance as at 30/06/2017 : 182,119
Number of shares purchased : 16,002
Number of shares sold : 2
1 June 2017
Begining of the program 05/03/2012
Balance as at 31/05/2017 : 218,205
Number of shares purchased : 51,001
Number of shares sold : 87,087
1 May 2017
Begining of the program 05/03/2012
Balance as at 30/04/2017 : 151,005
Number of shares purchased : 84,202
Number of shares sold : 17,002
1 April 2017
Begining of the program 05/03/2012
Balance as at 31/03/2016 : 133,127
Number of shares purchased : 44,707
Number of shares sold : 31,578
1 April 2017
Begining of the program 05/03/2012
Balance as at 31/03/2017 : 198,005
Number of shares purchased : 55,000
Number of shares sold : 102,000
1 March 2017
Begining of the program 05/03/2012
Balance as at 29/02/2016 : 131,127
Number of shares purchased : 57,008
Number of shares sold : 55,008
1 March 2017
Begining of the program 05/03/2012
Balance as at 28/02/2017 : 79,940
Number of shares purchased : 155,000
Number of shares sold : 31,935
1 February 2017
Begining of the program 05/03/2012
Balance as at 31/01/2017 : 232,825
Number of shares purchased : 35,001
Number of shares sold : 192,886
1 January 2017
Begining of the program 05/03/2012
Balance as at 31/12/2016 : 216,025
Number of shares purchased : 106,800
Number of shares sold : 90,000
1 December 2016
Begining of the program 05/03/2012
Balance as at 30/11/2016 : 186,025
Number of shares purchased : 90,000
Number of shares sold : 60,000
1 November 2016
Begining of the program 05/03/2012
Balance as at 31/10/2016 : 192,970
Number of shares purchased : 125,003
Number of shares sold : 131,948
1 October 2016
Begining of the program 05/03/2012
Balance as at 30/09/2016 : 197,970
Number of shares purchased : 75,000
Number of shares sold : 80,000
1 September 2016
Begining of the program 05/03/2012
Balance as at 31/08/2016 : 111,205
Number of shares purchased : 115,003
Number of shares sold : 28,238
1 August 2016
Begining of the program 05/03/2012
Balance as at 31/07/2016 : 124,205
Number of shares purchased : 72,005
Number of shares sold : 85,005
1 July 2016
Begining of the program 05/03/2012
Balance as at 30/06/2016 : 141,014
Number of shares purchased : 118,703
Number of shares sold : 135,512
1 June 2016
Begining of the program 05/03/2012
Balance as at 31/05/2016 : 171,305
Number of shares purchased : 55,505
Number of shares sold : 85,796
1 May 2016
Begining of the program 05/03/2012
Balance as at 30/04/2016 : 146,256
Number of shares purchased : 47,060
Number of shares sold : 22,011
1 February 2016
Begining of the program 05/03/2012
Balance as at 31/01/2016 : 167,227
Number of shares purchased : 53,904
Number of shares sold : 90,004
1 January 2016
Begining of the program 05/03/2012
Balance as at 31/12/2015 : 135,227
Number of shares purchased : 47,001
Number of shares sold : 15,001
1 December 2015
Begining of the program 05/03/2012
Balance as at 30/11/2015 : 130,227
Number of shares purchased : 115,001
Number of shares sold : 110,001
1 November 2015
Begining of the program 05/03/2012
Balance as at 31/10/2015 : 120,753
Number of shares purchased : 108,669
Number of shares sold : 99,195
1 October 2015
Begining of the program 05/03/2012
Balance as at 30/09/2015 : 91,803
Number of shares purchased : 116,005
Number of shares sold : 87,055
1 September 2015
Begining of the program 05/03/2012
Balance as at 31/08/2015 : 128,858
Number of shares purchased : 87,010
Number of shares sold : 124,065
1 August 2015
Begining of the program 05/03/2012
Balance as at 31/07/2015 : 98,141
Number of shares purchased : 71,506
Number of shares sold : 40,789
1 July 2015
Begining of the program 05/03/2012
Balance as at 30/06/2015 : 105,566
Number of shares purchased : 26,579
Number of shares sold : 34,004
1 June 2015
Begining of the program 05/03/2012
Balance as at 31/05/2015 : 41,366
Number of shares purchased : 135,002
Number of shares sold : 70,802
1 May 2015
Begining of the program 05/03/2012
Balance as at 30/04/2015 : 89,926
Number of shares purchased : 35,443
Number of shares sold : 84,003
1 April 2015
Begining of the program 05/03/2012
Balance as at 31/03/2015 : 103,207
Number of shares purchased : 80,000
Number of shares sold : 93,281
1 March 2015
Begining of the program 05/03/2012
Balance as at 28/02/2015 : 69,423
Number of shares purchased : 151,252
Number of shares sold : 117,468
1 February 2015
Begining of the program 05/03/2012
Balance as at 31/01/2015 : 58,695
Number of shares purchased : 149,000
Number of shares sold : 138,272
1 January 2015
Begining of the program 05/03/2012
Balance as at 31/12/2014 : 102,620
Number of shares purchased : 186,076
Number of shares sold : 230,001
28/06/2024
Inertam will treat 4,500 Italian tonnes of asbestos waste
24/05/2024
Information relating to the final number of Europlasma shares subject to reverse split
22/05/2024
Agreement to manufacture and supply 500,000 hollow shapes on behalf of Bizzell Europe
17/05/2024
Bizzell Europe acquires a 25% stake in Valdunes Industries for €5m
30/04/2024
Publication of the Group's 2023 financial statements is postponed
24/04/2024
Implementation of new bond financing with a maximum nominal amount of 30 million euros over 36 months in the form of OCABSA implying a potential dilution of more than 99% of the capital
17/04/2024
End of exclusive discussions with a view to a merger with Adomos
20/03/2024
Europlasma's offer to take over MG-Valdunes approved by the Commercial Court
29/02/2024
MG-Valdunes takeover project: lifting of suspensive conditions and financial commitments
25/01/2024
11/01/2024
09/01/2024
14/12/2023
A second expert firm confirms the valuation of the Forges de Tarbes at more than €56 million
12/12/2023
An independent expertise values the Forges de Tarbes at €56 million
07/12/2023
Entry into exclusive negotiations to emerge on the stock market a new player focused on the defense sector
02/11/2023
Signature of an agreement to develop a process for recycling Lithium-ion battery electrodes with a Chinese investment fund
25/09/2023
Project to develop a process for recycling parts of Lithium-ion batteries with a Chinese investment fund
11/08/2023
The State supports the investment plan of Forges de Tarbes
08/08/2023
ERRRATUM : Number of shares and voting rights as at 31/07/2023
03/08/2023
Inertam wins a contract estimated at €15 million in Algeria
17/07/2023
Cooperation and supply agreement of 120,000 blanks per year between Les Forges de Tarbes and a Ukrainian state-owned company
13/07/2023
New Alliance for Definitive Treatment of asbestos waste from the African continent
11/07/2023
Provisional allocation contract for the treatment of 7,000 tonnes of asbestos waste from an Algerian site
22/06/2023
Results of the General Meeting of Shareholers on 20 June 2023
15/06/2023
New order for 6,000 hollow shapes and acceleration of debt reduction as well as investments
06/06/2023
Final development phase aimed at validating the fly ash vitrification process in China
05/06/2023
500 tonnes of Italian asbestos arrive in France to be destroyed at high temperature on Inertam's site
02/06/2023
150 tonnes of asbestos waste from the African continent will be vitrified in France, at Inertam
31/05/2023
Provision of documents to the Extraordinary and Ordinary General Meeting of shareholders
19/04/2023
Exercise of the investor call: draw down of a second tranche of 200 OCEANE
19/04/2023
Building project of a first aluminum druss treatment plant in China
11/04/2023
Terms and conditions for the free allocation of share subscription warrants to all Europlasma's shareholders
30/03/2023
Signing of a new partnership agreement for the final treatment of asbestos waste from the African continent
24/03/2023
Signing of a second partnership agreement in Algeria and first order for the final treatment of asbestos waste
23/03/2023
Implementation of a new bond financing of a maximum nominal amount of 15 million euros over 36 months in the form of OCEANE-BSA and free allocation of stock warrants for the benefit of all the company's shareholders
28/02/2023
Exercise of the last equity warrants by the Global Corporate Finance Opportunities fund and Europlasma deleveraging
21/02/2023
New referencing of Inertam in Italy through the collaboration with the company Furia
20/02/2023
Capital increase inherent in the exercise of stock warrants by the Global Corporate Finance Opportunities Fund: Europlasma continues its debt reduction
09/02/2023
Entry into exclusive negotiations for the acquisition of Terbis
06/02/2023
Capital increase of €1.5 million to deleverage the Group and seize new investment opportunities
19/12/2022
Inertam receives a new transalpine order for the treatment of 1,500 tonnes of asbestos waste
16/12/2022
End of the share consolidation operation and first listing of new shares
30/11/2022
New authorisation for the reception of 500 tonnes of italian asbestos waste
25/11/2022
Europlasma adapts its activities to the energy situation
09/11/2022
End of convertible bonds conversion and information relating to the definitive number of europlasma shares consolidation
03/11/2022
The French State renews its confidence and chooses Inertam's solution for its asbestos waste
17/10/2022
Europlasma registers a new order amounting to more than €8 million
05/10/2022
TO NOTES CONVERTIBLE INTO SHARES
28/09/2022
21/09/2022
01/09/2022
Signature of a framework agreement between Inertam and the Algerian company SO.GE.B. ZRITA for the final treatment of asbestos waste under the Basel convention
18/08/2022
Europlasma validates a technology that reduces the consumption of its vitrification processes by more than 40%
04/08/2022
Integration of Satma Industries: gain on acquisition of +€7m in the consolidated half-year financial statements as of june 30, 2022
24/06/2022
23/06/2022
Field Intelligence Energy accelerates in depollution in Latin America with investments in green hydrogen
08/06/2022
Ordinary and extraordinary General Meeting on 7 June 2022
30/05/2022
Asbestos waste : Italy returns to vitrification with Inertam
19/05/2022
Installation of the fly ash vitrification pilot in China and lauch of a test campaign
17/05/2022
Ordinary and Extraordinary General Meeting of Shareholders : documentation at disposal
12/05/2022
Industrial revitalization and optimization of Satma Industries, European specialist in the processing of aluminum foil for the production of high value-added industrial capacitors
09/05/2022
06/05/2022
25/04/2022
€1.7 million from "Région Nouvelle Aquitaine" to Europlasma
01/04/2022
25/03/2022
Europlasma takes over SATMA PPC, a leading producer of electronic components from treatment of aluminium foil
17/03/2022
Asbestos waste : signature of a framework agreement with a major waste player in Switzerland
25/02/2022
27/01/2022
31/01/2022
27/01/2022
03/01/2022
Exercise of the investor call leading to the issuance of 2 tranches of 100 convertible bonds into shares
24/12/2021
16/12/2021
15/12/2021
16/11/2021
Discussions under progress with NCC environnement for the creation of an asbestos and pcb vitrification unit in Algeria
11/11/2021
27/09/2021
17/09/2021
26/07/2021
16/07/2021
Drum waste : signature of a first letter of intent in China
05/07/2021
Entry in negotiation for the supply of a aluminum waste treatment plant in China
02/07/2021
Positive step forward with the acquisition project of Tarbes Industry
07/06/2021
Ordinary General Meeting of 08/06/2021 : provisional quorum
25/05/2021
Drawdown of 3 tranches of 100 convertible notes with warrants attached
20/05/2021
Inertam continues its collaboration with "Région Auvergne Rhône Alpes" and renews its ambition to develop new capacities for final asbestos waste treatment
19/05/2021
Inertam: new optimization phase of the asbestos waste vitrification line
18/05/2021
Information relative to the Ordinary General Meeting of Shareholders on 08/06/2021
17/05/2021
The pilot furnace for aluminium waste treatment in China is built
29/04/2021
Europlasma confirms its eligibility for the French PEA-PME regime
21/04/2021
Drawdown of 5 tranche of 100 convertible notes with warrants attached
16/04/2021
Set up of bond financing of up to € 100M over 7 years by OCABSA’s issuance to support the second phase of Europlasma's development
24/03/2021
Europlasma continues its development to depollute the oil industy
19/03/2021
Solid Refused Fuels: First multi-year contract of at least € 4.5 million over 5 years
18/03/2021
Drawdown of the last Tranche 15 of 200 convertible notes
24/02/2021
Extraordinary General Meeting of Shareholders on 24/02/2021 - Results
15/02/2021
Extraordinary General Meeting of Shareholders on 24/02/2021
08/02/2021
Information relative to the Extraordinary General Meeting of Shareholders on 24/02/2021
04/02/2021
Information relative to the number of shares and voting rights as at 31/01/2021
19/01/2021
Extraordinary General Meeting of Shareholders convened on 24/02/2021
06/01/2021
Information relative to the number of shares and voting rights as at 31/12/2020
29/12/2020
Inertam treated 2,300 tonnes of waste along second half of 2020
28/12/2020
Europlasma's deleveraging : issue of 650 convertible bonds for the benefit of Global Tech Opportunities 1 Fund
28/12/2020
Group's deleveraging validated by the Extraordinary General Meeting of Shareholders on 28/12/2020
11/12/2020
Information relative to the Extraordinary General Meeting of Shareholders on 28/12/2020
09/12/2020
Extraordinary General Meeting of Shareholders on 28/12/2020 behind closed doors
04/12/2020
Information relative to the number of shares and voting rights as at 30/11/2020
20/11/2020
Extraordinary Shareholders' Meeting convened on 18/12/2020 behind closed doors
13/11/2020
Restructuring of CHO Morcenx's debt allowing massive deleveraging of the group
04/11/2020
Information relative to the number of shares and voting rights as at 31/10/2020
23/10/2020
Postponement of the extraordinary shareholders' meeting convened on 28/10/2020
12/10/2020
Extraordinary General Meeting of Shareholders convened on 28/10/2020
05/10/2020
Information relative to the number of shares and voting rights as at 30/09/2020
15/09/2020
Europlasma and Hangzhou University approve the creation of a research center for the treatment of fly ash and the recycling of aluminum.
03/09/2020
Information relative to the number of shares and voting rights as at 31/08/2020
31/08/2020
Ordinary and extraordinary General Meeting on 31/08/2020 - Quorum not reached, Second General Meeting on 22/09/2020
28/08/2020
Ordinary and extraordinary General Meeting on 31/08/2020 - Provisional quorum
14/08/2020
Call to the ordinary and extraordinary General Meeting on 31/08/2020
06/08/2020
Information relative to the number of shares and voting rights as at 31/07/2020
20/07/2020
Europlasma accelerates the pace of its financing in order to support its development strategy
06/07/2020
Listing of new shares from reverse stock split and rights' adjustments of other securities.
03/07/2020
Information relative to the number of shares and voting rights as at 30/06/2020
02/07/2020
The National Assembly chooses Europlasma for the treatment of asbestos
11/06/2020
Restart of Inertam, a new major step in the strategic plan
08/06/2020
Information relative to the number of shares and voting rights as at 31/05/2020
04/06/2020
Technical informations on Europlasma's shares consolidation
07/05/2020
Information relative to the number of shares and voting rights as at 30/04/2020
07/04/2020
Information relative to the number of shares and voting rights as at 31/03/2020
01/04/2020
Extraodinary Shareholders meeting of 6 April, 2020 behind closed doors
18/03/2020
Invitation to the Extraordinary Shareholder's meeting on 6 April, 2020
06/03/2020
Information relative to the number of shares and voting rights as at 29/02/2020
28/02/2020
Consolidation of shares planned and equity financing secured
05/02/2020
Information relative to the number of shares and voting rights as at 31/01/2020
10/01/2020
Information on number of voting rights and shares as at 31/12/2019
08/01/2020
Letter of intent for the final treatment of fly ash for 4 waste incinerators in China
17/12/2019
Cooperation agreement with the city of LaiXi for the deployment of the Group's technologies in China
03/09/2019
Issuance of 3,000 warrants given access to notes convertible into shares with shares subscription warrants attached (BEOCABSA)
01/08/2019
General Management strengthened: Olivier Pla appointed as Deputy Chief Executive Officer of the Group
31/07/2019
Invitation to the ordinary and extraordinary Shareholders' meeting of August 20, 2019.
21/01/2019
Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today before the opening of the stock exchange.
12/11/2018
Europlasma announces the suspension of the exercise of the 4th warrant given access to convertible bonds.
06/11/2018
Information relative to the number of shares and voting rights as at 31/10/2018
05/09/2018
Europlasma announces the signature of a partnership framework agreement with Orano Cycle and the progression of discussions with financial investors to have a reference sharholder
04/09/2018
Information relative to number of shares and voting rights as at 31/08/2018
03/09/2018
Europlasma announces the suspension of the exercise of the 3rd warrant given access to convertible bonds.
08/08/2018
Information relative to number of shares and voting rights as at 31st July.
05/07/2018
Information relative to number of shares and voting rights as at 30 June.
14/05/2018
Information relative to number of shares and voting rights as at 30 April.
13/04/2018
Europlasma announces an agreement with European High Growth Opportunities Securitization Fund improving the conditions of the 3rd tranche of convertible bonds
05/04/2018
Information relative to number of shares and voting rights as at 31 March.
28/03/2018
EIB and Europlasma announce the signature of a € 30 million financing contract for the innovative CHO Tiper project
22/03/2018
Europlasma announces a capital increase in its subsidiary CHO Power, valuing it at €101 million, and a simultaneous reorganisation of CHO Morcenx
26/02/2018
Europlasma commits alongside Arcelor Mittal to reducing the carbon footprint of the steel industry
09/02/2018
Convertible bonds financing contract for a maximum amount of EUR 8 million
20/12/2017
BEI announces its intention to support the CHO Tiper project by providing up to 30 million euro
06/09/2017
Delivery of the plasma facility for the treatment of low-level radioactive waste in Bulgaria
21/03/2017
CHO Morcenx power plant: update on the acceptance of the second GE Jenbacher engine
20/02/2017
CHO Morcenx power plant: acceptance of the first Jenbacher engine successfully performed